Cipla gets DCGI nod to sell Covid-19 drug Favipiravir under brand ‘Ciplenza’, to be launched in first week of August
Mumbai: Drug maker Cipla Ltd. on Friday said it has received regulatory approval from Drug Controller General of India (DCGI)...
Mumbai: Drug maker Cipla Ltd. on Friday said it has received regulatory approval from Drug Controller General of India (DCGI)...